Article Dans Une Revue npj Biofilms and Microbiomes Année : 2024

Christensenella minuta protects and restores intestinal barrier in a colitis mouse model by regulating inflammation

Résumé

Christensenella minuta DSM 22607 has recently been suggested as a potential microbiome-based therapy for inflammatory bowel disease (IBD) because it displays strong anti-inflammatory effects both in vitro and in vivo. Here, we aimed to decipher the mechanism(s) underlying the DSM 22607mediated beneficial effects on the host in a mouse model of chemically induced acute colitis. We observed that C. minuta plays a key role in the preservation of the epithelial barrier and the management of DNBS-induced inflammation by inhibiting interleukin (IL)-33 and Tumor necrosis factor receptor superfamily member 8 (Tnfrsf8) gene expression. We also showed that DSM 22607 abundance was positively correlated with Akkermansia sp. and Dubosiella sp. and modulated microbial metabolites in the cecum. These results offer new insights into the biological and molecular mechanisms underlying the beneficial effects of C. minuta DSM 22607 by protecting the intestinal barrier integrity and regulating inflammation.

Fichier principal
Vignette du fichier
s41522-024-00540-6.pdf (2.72 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Licence

Dates et versions

hal-05071299 , version 1 (16-05-2025)

Licence

Identifiants

Citer

Camille Kropp, Kevin Tambosco, Sead Chadi, Philippe Langella, Sandrine P Claus, et al.. Christensenella minuta protects and restores intestinal barrier in a colitis mouse model by regulating inflammation. npj Biofilms and Microbiomes, 2024, 10 (1), pp.88. ⟨10.1038/s41522-024-00540-6⟩. ⟨hal-05071299⟩
70 Consultations
90 Téléchargements

Altmetric

Partager

  • More